Biosynex SA (ALBIO) Stock Price & News

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	25.26M	25.26M	22.33M	22.33M
Cost of goods sold	10.47M	10.47M	10.95M	10.95M
Cost of revenue	10.47M	10.47M	10.95M	10.95M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	8.75M	8.75M	7.71M	7.71M
Operating expense	31.70M	31.70M	7.50M	7.50M
Total operating expenses	42.17M	42.17M	18.45M	18.45M
Operating income	-16.90M	-16.90M	3.88M	3.88M
Other non operating income	619.50K	619.50K	140.00K	140.00K
EBT including unusual items	-25.21M	-25.21M	-4.41M	-4.41M
EBT excluding unusual items	-17.71M	-17.71M	3.10M	3.10M
Income tax expense	-956.50K	-956.50K	407.50K	407.50K
Effective tax rate	3.79%	3.79%	-9.23%	-9.23%
Other operating expenses	5.56M	5.56M	-93.00K	-93.00K
Net income	-24.29M	-24.29M	-4.82M	-4.82M
Net profit margin	-96.15%	-96.15%	-21.58%	-21.58%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-1.36M	-1.36M	-862.50K	-862.50K
Net interest expenses	-1.36M	-1.36M	-862.50K	-862.50K
Depreciation and amortization charges	5.07M	5.07M	-114.00K	-114.00K
EBITDA	-3.19M	-3.19M	10.52M	6.98M
Gain or loss from assets sale	-716.50K	-716.50K	-2.96M	-2.96M

Finance